Farrell Michael J.'s Form 4 filing
Resmed Inc (RMD) · filed Nov 14, 2022
- Accession no.
- 0001127602-22-025406
- Filed
- Nov 14, 2022
- Trade date
- Nov 10, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.08M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farrell Michael J.CIK 0001485164 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | ResMed Common Stock | GGiftDisposed | −1,000 | $0.00 | $0 | 4,090 | Indirect | |
| Nov 10, 2022 | ResMed Common Stock | GGiftAcquired | +1,000 | $0.00 | $0 | 4,880 | Indirect | |
| Nov 10, 2022 | ResMed Common Stock | SSaleDisposed | −4,880 | $220.83F3 | −$1,077,650.4 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $220.67 $220.97. The price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.